Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TARA Protara Therapeutics, Inc. Common Stock
$2.47 5.11% +0.12
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TARA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Protara Therapeutics, Inc. Common Stock (TARA)

Loading

Key Stats

Market cap. 146.0M
Enterprise value -2052513
Trailing PE -1.8358209239903
Forward PE -1.3776548
PEG Ratio -0.64253732339659
Enterprise to EBITDA 0.027
Price to book MRQ 0.8534798

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
EBITDA -76449000
Diluted EPS TTM -1.36
Total Cash (MRQ) 142.5M
Current ratio (MRQ) 10.973
Operating Cash Flow (TTM) -66134000

TARA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TARA News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.